NCT02300987 2020-10-26A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent ProgressionNovartisPhase 2 Completed10 enrolled 12 charts